je.st
news
Celladon Terminates Development of Gene Therapy Mydicar
2015-06-26 16:43:09| Trucking - Topix.net
Celladon Corporation , today confirmed its plans to suspend further research or development of its MYDICAR program and its other pre-clinical programs including the Stem Cell Factor gene therapy and SERCA2b small molecule programs. Earlier in the month the Company announced the engagement of Wedbush PacGrow Healthcare as its exclusive financial advisor and a strategic plan pursuant to which the Company immediately commenced a process to seek a merger or sale.
Tags: development
therapy
gene
terminates
Category:Transportation and Logistics